These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 38182990)

  • 1. Differential distribution of linezolid in diseased and nondiseased bones in patients with spinal tuberculosis.
    Li Y; Lei G; Dong W; Lan T; Fan J; Qin S
    BMC Infect Dis; 2024 Jan; 24(1):50. PubMed ID: 38182990
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Penetration of linezolid into bone tissue 24 h after administration in patients with multidrug-resistant spinal tuberculosis.
    Li Y; Huang H; Dong W; Lan T; Fan J; Wen S; Zhang T; Qin S; Guo A
    PLoS One; 2019; 14(10):e0223391. PubMed ID: 31581274
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Distribution of Linezolid in Tuberculosis Lesions in Patients with Spinal Multidrug-Resistant Tuberculosis.
    Li Y; Dong W; Lan T; Fan J; Qin S; Guo A
    Antimicrob Agents Chemother; 2020 Jun; 64(7):. PubMed ID: 32366717
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bone penetration of linezolid in osteoarticular tuberculosis patients of China.
    Wen S; Zhang T; Yu X; Dong W; Lan T; Fan J; Xue Y; Wang F; Dong L; Qin S; Huang H
    Int J Infect Dis; 2021 Feb; 103():364-369. PubMed ID: 33278623
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of efficacy and safety of linezolid-based chemotherapeutic regimens for patients with postoperative multidrug-resistant spinal tuberculosis.
    Qiao J; Yang L; Feng J; Dai X; Xu F; Xia P
    Int J Infect Dis; 2022 May; 118():264-269. PubMed ID: 35339715
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intracellular Activity of Poly (DL-Lactide-co-Glycolide) Nanoparticles Encapsulated with Prothionamide, Pyrazinamide, Levofloxacin, Linezolid, or Ethambutol on Multidrug-Resistant
    Jiang H; Li X; Xing Z; Niu Q; Xu J
    Curr Drug Deliv; 2023; 20(3):306-316. PubMed ID: 35546770
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Decreased mortality seen in rifampicin/multidrug-resistant tuberculous meningitis treated with linezolid in Shenzhen, China.
    Fang MT; Su YF; An HR; Zhang PZ; Deng GF; Liu HM; Mao Z; Zeng JF; Li G; Yang QT; Wang ZY
    BMC Infect Dis; 2021 Sep; 21(1):1015. PubMed ID: 34583653
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interactions of linezolid and second-line anti-tuberculosis agents against multidrug-resistant Mycobacterium tuberculosis in vitro and in vivo.
    Zhao W; Zheng M; Wang B; Mu X; Li P; Fu L; Liu S; Guo Z
    Int J Infect Dis; 2016 Nov; 52():23-28. PubMed ID: 27613365
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of
    Zong Z; Jing W; Shi J; Wen S; Zhang T; Huo F; Shang Y; Liang Q; Huang H; Pang Y
    Antimicrob Agents Chemother; 2018 Aug; 62(8):. PubMed ID: 29844043
    [TBL] [Abstract][Full Text] [Related]  

  • 10. First report of whole-genome analysis of an extensively drug-resistant Mycobacterium tuberculosis clinical isolate with bedaquiline, linezolid and clofazimine resistance from Uganda.
    Kabahita JM; Kabugo J; Kakooza F; Adam I; Guido O; Byabajungu H; Namutebi J; Namaganda MM; Lutaaya P; Otim J; Kakembo FE; Kanyerezi S; Nabisubi P; Sserwadda I; Kasule GW; Nakato H; Musisi K; Oola D; Joloba ML; Mboowa G
    Antimicrob Resist Infect Control; 2022 May; 11(1):68. PubMed ID: 35550202
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Linezolid for patients with multidrug-resistant tuberculosis/extensively drug-resistant tuberculosis in China.
    Zhang P; Tan J; Lin Y; Zhang H; Deng G; Chen X
    Drug Discov Ther; 2022 May; 16(2):96-98. PubMed ID: 35444071
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of the pharmacokinetics of two dosage regimens of linezolid in multidrug-resistant and extensively drug-resistant tuberculosis patients.
    Alffenaar JW; van Altena R; Harmelink IM; Filguera P; Molenaar E; Wessels AM; van Soolingen D; Kosterink JG; Uges DR; van der Werf TS
    Clin Pharmacokinet; 2010 Aug; 49(8):559-65. PubMed ID: 20608757
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Linezolid in the treatment of extensively drug-resistant tuberculosis.
    Zhang L; Pang Y; Yu X; Wang Y; Gao M; Huang H; Zhao Y
    Infection; 2014 Aug; 42(4):705-11. PubMed ID: 24902521
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Study on the resistance of rifampicin-resistant Mycobacterium tuberculosis to anti-tuberculosis drugs in group A].
    Dai XW; Li CY; Wang NH; Chen SS; Tian LL; Zhao YF; Tao LY; Yang XY; Ding BC; He XX
    Zhonghua Jie He He Hu Xi Za Zhi; 2023 Nov; 46(11):1110-1117. PubMed ID: 37914422
    [No Abstract]   [Full Text] [Related]  

  • 15. Linezolid-containing regimens for the treatment of drug-resistant tuberculosis in South African children.
    Rose PC; Hallbauer UM; Seddon JA; Hesseling AC; Schaaf HS
    Int J Tuberc Lung Dis; 2012 Dec; 16(12):1588-93. PubMed ID: 23032215
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Population pharmacokinetics and target attainment analysis of linezolid in multidrug-resistant tuberculosis patients.
    Tietjen AK; Kroemer N; Cattaneo D; Baldelli S; Wicha SG
    Br J Clin Pharmacol; 2022 Feb; 88(4):1835-1844. PubMed ID: 34622478
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Evaluation of the mycobacterium efficacy of linezolid in vitro].
    Huang HR; Yu X; Jiang GL; Dai GM; Bi ZQ; Ma Y
    Zhonghua Jie He He Hu Xi Za Zhi; 2011 Aug; 34(8):575-8. PubMed ID: 22168977
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Linezolid Pharmacokinetics in South African Patients with Drug-Resistant Tuberculosis and a High Prevalence of HIV Coinfection.
    Wasserman S; Denti P; Brust JCM; Abdelwahab M; Hlungulu S; Wiesner L; Norman J; Sirgel FA; Warren RM; Esmail A; Dheda K; Gandhi NR; Meintjes G; Maartens G
    Antimicrob Agents Chemother; 2019 Mar; 63(3):. PubMed ID: 30617089
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A battery of tandem mass spectrometry assays with stable isotope-dilution for the quantification of 15 anti-tuberculosis drugs and two metabolites in patients with susceptible-, multidrug-resistant- and extensively drug-resistant tuberculosis.
    Mercier T; Desfontaine V; Cruchon S; Da Silva Pereira Clara JA; Briki M; Mazza-Stalder J; Kajkus A; Burger R; Suttels V; Buclin T; Opota O; Koehler N; Sanchez Carballo PM; Lange C; André P; Decosterd LA; Choong E
    J Chromatogr B Analyt Technol Biomed Life Sci; 2022 Nov; 1211():123456. PubMed ID: 36240540
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Therapeutic drug monitoring of cycloserine and linezolid during anti-tuberculosis treatment in Beijing, China.
    Zhu H; Guo SC; Liu ZQ; Wang B; Fu L; Chu NH; Lu Y
    Int J Tuberc Lung Dis; 2018 Aug; 22(8):931-936. PubMed ID: 29991404
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.